Therefore, if we consider both IL-36RA and IL-38 cytokines as potential IL-36 antagonists, only a minor subpopulation of patients with RA (17–29%) have an elevated agonist/antagonist ratio [85,121]. The gene discussed is IL36RN; the disease is rheumatoid arthritis.